Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
PepFactor Skin
- Development stage
- Unknown
- Lead developer
- ReGen Factor
- Modality
- Recombinant Proteins and Enzymes
- Administration
- Topical
01
Overview
PepFactor Skin is a cosmeceutical product developed by ReGen Factor, featuring bio-identical recombinant basic fibroblast growth factor (bFGF) as its active ingredient. Produced using a proprietary yeast-based recombinant technology, this large molecule biologic is designed to mimic natural human bFGF. Its mechanism of action involves binding to and activating fibroblast growth factor receptors (FGFRs), which triggers cellular signaling pathways that promote fibroblast proliferation, enhance the production of collagen and elastin, and support angiogenesis. These processes facilitate tissue regeneration and improve skin elasticity, making it suitable for treating anti-aging skin conditions and acne. PepFactor Skin is administered topically, often in conjunction with professional skin treatments, and is marketed globally through medical and spa networks.
- Brand names
- PepFactor SkinPepFactor
- Other names
- recombinant basic fibroblast growth factorbFGFrecombinant bFGFFGF2FGF-2FGF 2
02
Targets
FGFR3 (Fibroblast growth factor receptor 3)FGFR4 (Fibroblast growth factor receptor 4)FGFR1 (Fibroblast growth factor receptor 1)FGFR2 (Keratinocyte growth factor receptor)
Beyond the preview
Go deeper on PepFactor Skin.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on PepFactor Skin.